Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

Trial Profile

Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs KD 018 (Primary) ; Capecitabine
  • Indications Adenocarcinoma; Rectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 Jul 2017 Planned End Date changed from 1 Jan 2018 to 1 Jul 2018.
    • 25 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
    • 06 Jun 2017 Preliminary result presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top